ZA906839B - Fusion proteins,their preparation and use - Google Patents

Fusion proteins,their preparation and use

Info

Publication number
ZA906839B
ZA906839B ZA906839A ZA906839A ZA906839B ZA 906839 B ZA906839 B ZA 906839B ZA 906839 A ZA906839 A ZA 906839A ZA 906839 A ZA906839 A ZA 906839A ZA 906839 B ZA906839 B ZA 906839B
Authority
ZA
South Africa
Prior art keywords
fusion proteins
manner
preparation
fusion protein
oligonucleotide
Prior art date
Application number
ZA906839A
Other languages
English (en)
Original Assignee
Hoechst Ag
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Gen Hospital Corp filed Critical Hoechst Ag
Publication of ZA906839B publication Critical patent/ZA906839B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA906839A 1989-08-29 1990-09-28 Fusion proteins,their preparation and use ZA906839B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39987489A 1989-08-29 1989-08-29

Publications (1)

Publication Number Publication Date
ZA906839B true ZA906839B (en) 1991-06-26

Family

ID=23581315

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906839A ZA906839B (en) 1989-08-29 1990-09-28 Fusion proteins,their preparation and use

Country Status (19)

Country Link
EP (1) EP0489780B1 (da)
JP (1) JP3043803B2 (da)
KR (1) KR0159786B1 (da)
AT (1) ATE173018T1 (da)
AU (1) AU638277B2 (da)
CA (1) CA2065146C (da)
CY (1) CY2168B1 (da)
DE (1) DE69032743T2 (da)
DK (1) DK0489780T3 (da)
ES (1) ES2124216T3 (da)
FI (1) FI113183B (da)
GR (1) GR1005153B (da)
HU (1) HU216069B (da)
IE (1) IE903120A1 (da)
IL (1) IL95495A (da)
NO (1) NO308667B1 (da)
PT (1) PT95111B (da)
WO (1) WO1991003550A1 (da)
ZA (1) ZA906839B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
DK0600372T3 (da) * 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
DK0622376T3 (da) * 1993-04-27 2001-11-12 Hoechst Ag Amorfe monosfæriske former af insulinderivater
WO1995009914A1 (en) * 1993-10-05 1995-04-13 Asahi Glass Company Ltd. Multicloning vector, expression vector, and production of foreign protein with expression vector
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US5683987A (en) * 1994-07-12 1997-11-04 The Board Of Regents Of The University Of Nebraska Therapeutic oligonucleotides targeting the human MDR1 and MRP genes
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de) 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US20060035316A1 (en) * 2002-11-12 2006-02-16 Sang-Yong Lee Plasmids expressing human insulin and the preparation method for human insuling thereby
DE102008025007A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
DE102008003568A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003566A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
EP2229406B1 (de) 2008-01-09 2015-04-22 Sanofi-Aventis Deutschland GmbH Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
DE102008025008A1 (de) 2008-05-24 2009-11-26 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
PL2451437T3 (pl) 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
DK2739646T3 (da) 2011-05-10 2018-02-26 Stefan Hermann Omfattende buffersystem til renaturering af human proinsulin eller proinsulin-derivater
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP5858945B2 (ja) 2012-03-15 2016-02-10 アークレイ株式会社 酵素を用いた測定方法
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
JP6976254B2 (ja) * 2015-09-18 2021-12-08 バイオネット ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツングBioNet Pharma GmbH Ｃｄ−ｒａｐ前駆体タンパク質の使用による、ｃｄ−ｒａｐの製造方法における発現およびフォールディングの改善
JP7460182B2 (ja) * 2019-02-19 2024-04-02 ザ、トラスティーズ オブ プリンストン ユニバーシティ フォールディングされたドメインおよびｒｎａ顆粒会合タンパク質ドメインの光制御オリゴマー化および相分離のためのシステムおよび方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
EP0195680A3 (en) * 1985-03-21 1987-06-10 Immunex Corporation The synthesis of protein with an identification peptide
DE3526995A1 (de) * 1985-07-27 1987-02-05 Hoechst Ag Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
NO308667B1 (no) 2000-10-09
FI113183B (fi) 2004-03-15
JPH05501799A (ja) 1993-04-08
FI920923A0 (fi) 1992-02-28
DK0489780T3 (da) 1999-07-19
GR900100635A (el) 1991-12-30
GR1005153B (el) 2006-03-13
AU6287290A (en) 1991-04-08
DE69032743D1 (de) 1998-12-10
AU638277B2 (en) 1993-06-24
JP3043803B2 (ja) 2000-05-22
PT95111A (pt) 1991-05-22
EP0489780B1 (en) 1998-11-04
ES2124216T3 (es) 1999-02-01
HU216069B (hu) 1999-04-28
WO1991003550A1 (en) 1991-03-21
HK1012026A1 (en) 1999-07-23
CY2168B1 (en) 2002-08-23
DE69032743T2 (de) 1999-06-17
EP0489780A1 (en) 1992-06-17
EP0489780A4 (en) 1992-08-12
HUT60327A (en) 1992-08-28
KR0159786B1 (ko) 1998-11-16
IE903120A1 (en) 1991-03-13
HU9200674D0 (en) 1992-08-28
PT95111B (pt) 1998-10-30
ATE173018T1 (de) 1998-11-15
IL95495A0 (en) 1991-06-30
CA2065146C (en) 2002-07-23
NO920774D0 (no) 1992-02-27
CA2065146A1 (en) 1991-03-01
NO920774L (no) 1992-04-28
IL95495A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
ZA906839B (en) Fusion proteins,their preparation and use
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
GB8717430D0 (en) Recombinant dna product
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
AU6569386A (en) Eukaryotic fusion proteins, the preparation and use thereof and means for carrying out the process
RU93045577A (ru) Слитные полипептиды
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
AU3461797A (en) Fas ligand-like protein, its production and use
ES8506347A1 (es) Un metodo para producir un polipeptido de tipo il-2-".
ATE419357T1 (de) Dna 19355 polypeptide, ein homolog des tumornekrosefaktors
NZ292565A (en) Production of stabilised complement protein-3 convertase
NZ333203A (en) Tumour antigen proteins, genes thereof, and tumour antigen peptides
IE811049L (en) Cloned fmdv antigens
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
EP0546087A4 (da)
EP0369816A3 (en) Monoclonal antibodies specific for human polymorphic epithelial mucin
ZA935117B (en) Anti-feline immunodeficiency virus (FIV) vaccines
GR3034725T3 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy.
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
IL78278A0 (en) Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules
JPS6474989A (en) Dna to code human lysozyme
PT1241179E (pt) Proteína humana possuindo actividade antiproliferativa in vitro
DK171489A (da) Peptidderivater
JPS6474988A (en) Synthetic gene of cystatin c, corresponding recombinant plasmid and recombinant